<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813213</url>
  </required_header>
  <id_info>
    <org_study_id>R-2013-3501-8</org_study_id>
    <nct_id>NCT02813213</nct_id>
  </id_info>
  <brief_title>Effectiveness Comparison of Skin Micro-grafts vs Meshed Split Thickness Skin Grafts</brief_title>
  <official_title>Effectiveness Comparison Between the Use of Skin Micro-grafts vs Meshed Split Thickness Skin Grafts in Cutaneous Defects: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coordinación de Investigación en Salud, Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coordinación de Investigación en Salud, Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double-blind randomized controlled clinical trial, that compares the percentage of
      epithelialization of skin defects using the conventional meshed split thickness skin grafts
      vs skin micro grafts.

      Two techniques will be applied in the same patient. The skin defect will be divided in two
      parts, and with a randomized method each half of this defect will be assigned to one of the
      two techniques.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Split thickness skin graft is the standard technique in skin defects reconstruction.

      The etiology of this problem is diverse (burns, infections, trauma, cancer) however, many
      times the availability of donor areas are insufficient and morbidity and complications that
      may arise make prohibitive the use of this technique in many situations.

      Skin micro grafts technique consists in using a very small part of skin (0.8x 0.8 mm) and
      keratinocyte growth-factor solution that allows a 1:50- 1:100 skin expansion. It has many
      advantages: it can be performed with local anesthesia and donor area is tiny.

      The study consists in using the conventional and the new technique in the same patient. The
      skin defect will be divided in two parts, and with a randomized method each half of this
      defect will be assigned to one of the two different techniques. The result variable will be
      the &quot;percentage of epithelialization&quot; and will be compared in the two halves. This variable
      will be measured at day 14 using clinical and image software methods. The patient and the
      investigator that record the outcome variable will be blinded to the type of technique.

      The investigators will take skin biopsies of two halves and will perform pathology studies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Experimental intervention: skin micro grafts Comparative intervention: Meshed Split Thikness Skin Grafts</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of epithelialization</measure>
    <time_frame>14th day</time_frame>
    <description>It will be measured with imaging software (comparing color density) in order to calculate the percentage of epithelialization at day 14 compared with the initial wound area</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Histological study</measure>
    <time_frame>14th day</time_frame>
    <description>Study of the histological characteristics of the skin under microscope</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical percentage of epithelialization</measure>
    <time_frame>14th day</time_frame>
    <description>It will be measured with the &quot;irregular patterns&quot; technique that uses different sizes of geometric patterns in order to calculate the area of a irregular surface. Epithelialization will be compared at day 14 compared with the initial wound area.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Skin Ulcer</condition>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Standard skin graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group is comprised of patients' wound halves that will receive meshed (1:3) split thickness skin graft (0.3-0.5mm thickness). This half will be covered with a standard &quot;tie over&quot; dressing. The dressing will be removed at day 5, and then it will be removed every 3 days up to the 14th day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Skin micro graft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group is comprised of the patients' wound halves that will receive skin micro grafts. To obtain this grafts the investigators will use &quot;Xpansion micro-autografting&quot; system. They will use 0.8 x 0.8 mm skin grafts with a graft to graft distance of 4mm (1:50 expansion).This half will be covered with a special hydrogel dressing with keratinocyte growth factor (Epilife medium with calcium) 1.5ml for each 14 square centimeters of the wound. This half will be covered with a wet adhesive foam dressing and then it will be covered up with a non-adherent interface dressing (tegaderm). The dressing will be removed at day 5, and then it will be removed every 3 days up to the 14th day. Each time of dressing change only the non-adherent interface dressing will be removed, and the area will be bathed with keratinocyte growth factor solution.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Skin micro Grafts</intervention_name>
    <description>0.8 x 0.8 skin micro graft with graft to graft distance of 4 cm (1:50 expansion) bathed with keratinocyte growth factor solution ( 1.5 ml for each 14 square centimeters of wound)</description>
    <arm_group_label>Skin micro graft</arm_group_label>
    <other_name>Xpansion micro auto grafting system</other_name>
    <other_name>micro grafts</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard skin graft</intervention_name>
    <description>Standard split thickness (0.3-0.5mm) skin graft</description>
    <arm_group_label>Standard skin graft</arm_group_label>
    <other_name>split thickness skin graft</other_name>
    <other_name>skin grafting</other_name>
    <other_name>skin grafts</other_name>
    <other_name>medium split thickness skin graft</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non complicated wounds (no infection, no cancer)

          -  Wound area: 20 x 20 cms or less

          -  Located in diverse anatomical regions (except axillar, groin, genital, sole, scalp and
             flexion or extension areas)

        Exclusion Criteria:

          -  High cardiovascular risk

          -  Patients with indication of a different technique
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alejandro Cruz, MD</last_name>
    <phone>5534242197</phone>
    <email>alejandrocruzsegura@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claudia Ramos</last_name>
    <phone>(52) 57245900</phone>
    <phone_ext>23190</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>&quot;La Raza&quot; Medical Center. IMSS</name>
      <address>
        <city>Azcapotzalco</city>
        <state>Mexico City</state>
        <zip>02990</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Ramos</last_name>
      <phone>(52) 57245900</phone>
      <phone_ext>23190</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Arturo Jaquez, MD</last_name>
      <phone>55 85359927</phone>
    </contact_backup>
    <investigator>
      <last_name>Alejandro Cruz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arturo Jaquez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <link>
    <url>http://www.steadmed.com</url>
    <description>Mincing device, Xpansion Micrografting System</description>
  </link>
  <results_reference>
    <citation>Chern PL, Baum CL, Arpey CJ. Biologic dressings: current applications and limitations in dermatologic surgery. Dermatol Surg. 2009 Jun;35(6):891-906. doi: 10.1111/j.1524-4725.2009.01153.x. Epub 2009 Apr 6. Review.</citation>
    <PMID>19397669</PMID>
  </results_reference>
  <results_reference>
    <citation>MEEK CP. Successful microdermagrafting using the Meek-Wall microdermatome. Am J Surg. 1958 Oct;96(4):557-8.</citation>
    <PMID>13571547</PMID>
  </results_reference>
  <results_reference>
    <citation>MEEK CP. Extensive severe burn treated with enzymatic debridement and microdermagrafting: case report. Am Surg. 1963 Jan;29:61-4.</citation>
    <PMID>13934413</PMID>
  </results_reference>
  <results_reference>
    <citation>TANNER JC Jr, VANDEPUT J, OLLEY JF. THE MESH SKIN GRAFT. Plast Reconstr Surg. 1964 Sep;34:287-92.</citation>
    <PMID>14209177</PMID>
  </results_reference>
  <results_reference>
    <citation>Green H, Rheinwald JG, Sun TT. Properties of an epithelial cell type in culture: the epidermal keratinocyte and its dependence on products of the fibroblast. Prog Clin Biol Res. 1977;17:493-500.</citation>
    <PMID>928463</PMID>
  </results_reference>
  <results_reference>
    <citation>Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975 Nov;6(3):331-43.</citation>
    <PMID>1052771</PMID>
  </results_reference>
  <results_reference>
    <citation>Munster AM. Use of cultured epidermal autograft in ten patients. J Burn Care Rehabil. 1992 Jan-Feb;13(1):124-6.</citation>
    <PMID>1572841</PMID>
  </results_reference>
  <results_reference>
    <citation>Wood FM, Stoner M. Implication of basement membrane development on the underlying scar in partial-thickness burn injury. Burns. 1996 Sep;22(6):459-62.</citation>
    <PMID>8884006</PMID>
  </results_reference>
  <results_reference>
    <citation>Chester DL, Balderson DS, Papini RP. A review of keratinocyte delivery to the wound bed. J Burn Care Rehabil. 2004 May-Jun;25(3):266-75. Review.</citation>
    <PMID>15273468</PMID>
  </results_reference>
  <results_reference>
    <citation>Lumenta DB, Kamolz LP, Frey M. Adult burn patients with more than 60% TBSA involved-Meek and other techniques to overcome restricted skin harvest availability--the Viennese Concept. J Burn Care Res. 2009 Mar-Apr;30(2):231-42. doi: 10.1097/BCR.0b013e318198a2d6.</citation>
    <PMID>19165111</PMID>
  </results_reference>
  <results_reference>
    <citation>Svensjö T, Pomahac B, Yao F, Slama J, Wasif N, Eriksson E. Autologous skin transplantation: comparison of minced skin to other techniques. J Surg Res. 2002 Mar;103(1):19-29.</citation>
    <PMID>11855913</PMID>
  </results_reference>
  <results_reference>
    <citation>Hackl F, Bergmann J, Granter SR, Koyama T, Kiwanuka E, Zuhaili B, Pomahac B, Caterson EJ, Junker JP, Eriksson E. Epidermal regeneration by micrograft transplantation with immediate 100-fold expansion. Plast Reconstr Surg. 2012 Mar;129(3):443e-452e. doi: 10.1097/PRS.0b013e318241289c.</citation>
    <PMID>22373992</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2016</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Coordinación de Investigación en Salud, Mexico</investigator_affiliation>
    <investigator_full_name>Alejandro Cruz Segura</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>skin transplantation</keyword>
  <keyword>grafting skin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Only some data will be shared (age, gender, diagnosis, area defect and epithelialization ratio). Photos will be shared only if the patients give their consent.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

